Trials / Completed
CompletedNCT00393211
Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)
A Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial to Assess the Efficacy and Safety of MK0663 in Patients With Chronic Low Back Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 319 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663, Etoricoxib / Duration of Treatment : 12 Weeks | |
| DRUG | Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks |
Timeline
- Start date
- 2000-04-01
- Primary completion
- 2000-11-01
- Completion
- 2000-11-01
- First posted
- 2006-10-27
- Last updated
- 2022-02-18
Source: ClinicalTrials.gov record NCT00393211. Inclusion in this directory is not an endorsement.